Acetazolamide Capsule
Product Images NDC 70710-1591

2 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 70710-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 01)

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 01)
Chemical structure diagram of acetazolamide, showing its molecular composition with labeled atoms including nitrogen, sulfur, oxygen, and methyl groups as part of its molecular framework.*
FDA Label Image

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 02)

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 02)
Acetazolamide extended-release capsules, 500 mg, oral dosage form. The label shows a single half-yellow, half-white capsule marked with 'XYL 34'. The product is labeled for prescription use only, available in a package of 100 capsules. Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.